Date: Tuesday 14th January 2020
Time: 14:00 - 15:00 GMT
Speaker: Richard Pugh (Mango Solutions)
Registration: To register for this free event, please click here.
Richard Pugh is Mango’s Chief Data Scientist, and has over 20 years’ experience of helping organisations add value with data and advanced analytics. As co-founder of Mango, Richard has led a wide range of ground-breaking data science projects for some of the most forward thinking companies in the world.
During his two decades in the industry, Richard has become a leader in the Data Science field. He started out with a BSc in Mathematics and Statistics from Bath University, which led to work as a consultant in the pharmaceutical sector. In 2002 he co-founded Mango, which allowed him to make his vision of proactive, data driven business culture a reality. In his day-to-day role, Richard spends much of his time advising clients from a variety of industries on data-driven strategies, while keeping up-to-date with the cutting edge commercial applications of data science.
Richard is incredibly passionate about supporting the R and Data Science communities. He co-authored the book “R in 24 Hours”, was the first president of the R Consortium, sits on the RSS Data Science Section Committee and regularly speaks at events. Richard uses his experience to help companies make better decisions through data, and remove any perceived constraints on the limits of data science, sharing that it can inform and transform all aspects of a business.
PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.
Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.
Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.